Peripheral blood stem cell mobilization in multiple myeloma (MM): High-dose cyclophosphamide plus G-CSF vs. G-CSF alone

被引：0
|
作者：
Goldschmidt, H [1 ]
Hegenbart, U [1 ]
Cremer, FW [1 ]
Kiel, K [1 ]
Moos, M [1 ]
机构：
[1] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [21] Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy
    G Spitzer
    D Adkins
    M Mathews
    W Velasquez
    C Bowers
    F Dunphy
    N Kronmueller
    R Niemeyer
    W McIntyre
    P Petruska
    Bone Marrow Transplantation, 1997, 20 : 921 - 930
  • [22] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    Afifi, S.
    Adel, N. G.
    Devlin, S.
    Duck, E.
    Vanak, J.
    Landau, H.
    Chung, D. J.
    Lendvai, N.
    Lesokhin, A.
    Korde, N.
    Reich, L.
    Landgren, O.
    Giralt, S.
    Hassoun, H.
    BONE MARROW TRANSPLANTATION, 2016, 51 (04) : 546 - 552
  • [23] Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study
    S Afifi
    N G Adel
    S Devlin
    E Duck
    J Vanak
    H Landau
    D J Chung
    N Lendvai
    A Lesokhin
    N Korde
    L Reich
    O Landgren
    S Giralt
    H Hassoun
    Bone Marrow Transplantation, 2016, 51 : 546 - 552
  • [24] Use of concurrent G-CSF plus GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
    Madero, L
    González-Vicent, M
    Molina, J
    Madero, R
    Quintero, V
    Díaz, MA
    BONE MARROW TRANSPLANTATION, 2000, 26 (04) : 365 - 369
  • [25] Comparing Cyclophosphamide with G-CSF and Plerixafor with G-CSF As Stem Cell Mobilization (SCM) Regimens for Multiple Myeloma (MM) Patients: An Evaluation of Mobilization Efficacy and Toxicity
    Tan, Carlyn Rose C.
    Pancari, Philip A.
    Ulicny, John
    Martin, Mary Ellen
    Barta, Stefan Klaus
    Kropf, Patricia Lamont
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S136 - S136
  • [26] A randomized phase II study of stem cell mobilization with cyclophosphamide plus G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma
    Silvennoinen, R.
    Anttila, P.
    Saily, M.
    Lundan, T.
    Heiskanen, J.
    Siitonen, T. M.
    Kakko, S.
    Putkonen, M.
    Ollikainen, H.
    Terava, V.
    Kutila, A.
    Launonen, K.
    Rasanen, A.
    Sikio, A.
    Suominen, M.
    Bazia, P.
    Kananen, K.
    Selander, T.
    Kuittinen, T.
    Remes, K.
    Jantunen, E.
    BONE MARROW TRANSPLANTATION, 2016, 51 (03) : 372 - 376
  • [27] COMPARISON OF CE CHEMOTHERAPY PLUS G-CSF VS. G-CSF ALONE FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL MOBILIZATION IN PATIENTS WITH MULTIPLE MYELOMA: A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Hildebrandt, Martin
    Dill, Veronika
    Bluem, Philipp
    Lindemann, Anja
    Biederstaedt, Alexander
    Hoegner, Marion
    Goetze, Katharina
    Basssermann, Florian
    BONE MARROW TRANSPLANTATION, 2024, 59 : 657 - 658
  • [28] Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients
    Kröger, N
    Zeller, W
    Fehse, N
    Hassan, HT
    Krüger, W
    Gutensohn, K
    Lölliger, C
    Zander, AR
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (04) : 1101 - 1106
  • [29] PBPC mobilization in multiple myeloma: High-dose chemotherapy plus G-CSF vs two different dosages of G-CSF during steady-state.
    Goldschmidt, H
    Hegenbart, U
    Cremer, F
    Kiel, K
    Wallmeier, M
    Hohaus, S
    Haas, R
    Moos, M
    BLOOD, 1996, 88 (10) : 1610 - 1610
  • [30] G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis
    Antar, Ahmad
    Otrock, Zaher
    Kharfan-Dabaja, Mohamed
    Abou Ghaddara, Hussein
    Kreidieh, Nabila
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
12345